sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. has submitted Form 8.3 to the Irish Takeover Panel, disclosing its stake in Mural Oncology plc. As of July 9, 2025, Vanguard holds 772,739 ordinary shares at $0.01 each, representing a 4.47% interest in Mural Oncology.
The disclosure indicates no other positions, such as cash-settled or stock-settled derivatives. The form confirms no other parties connected to this offer and no agreements affecting voting rights or future acquisitions were mentioned.
Additionally, Vanguard reported a recent transaction involving the sale of 48 ordinary shares of Mural Oncology at a unit price of 2.56 USD. No indemnity or option arrangements have been established in connection to Mural Oncology's securities.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.